RUNX1T1 and acute myeloid leukemia: To determine whether the in vivo activity of anti‐miR‐383 is selective against AML‐ETO+ AML, t(8;21)− HL‐60 cells were inoculated subcutaneously and intratumourally injected with anti‐miR‐383 or scramble oligonucleotides as described above.